MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
about
Clinical significance of microRNAs in chronic and acute human leukemiaHigh expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.Developments in Hematopoietic Stem Cell Expansion and Gene Editing Technologies.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndrome.
P2860
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNA-223 dose levels fine ...... rs and acute myeloid leukemia.
@en
type
label
MicroRNA-223 dose levels fine ...... rs and acute myeloid leukemia.
@en
prefLabel
MicroRNA-223 dose levels fine ...... rs and acute myeloid leukemia.
@en
P2093
P2860
P50
P1476
MicroRNA-223 dose levels fine ...... ors and acute myeloid leukemia
@en
P2093
Aly Karsan
Andrew Muranyi
Arefeh Rouhi
Bob Argiropoulos
Christian Buske
Daniel T Starczynowski
Donna Hogge
Fernando D Camargo
Florian Kuchenbauer
Francesco Boccalatte
P2860
P304
858-868.e7
P356
10.1016/J.EXPHEM.2015.05.018
P577
2015-07-08T00:00:00Z